Return to homepagePandemic Pact

Attenuating lung injury during prolonged ventilation for COVID-19

  • Funded by Health Research Council of New Zealand
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $98,805.97

  • Funder

    Health Research Council of New Zealand

  • Principal Investigator

    Prof. Anthony Phillips

  • Research Location

    New Zealand

  • Lead Research Institution

    The University of Auckland

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The current COVID-19 infection pandemic is requiring prolonged ventilation support in many patients. We have a therapy (repurposed drug) expected to reduce lung injury in these clinical circumstances. This study will provide key initial experimental data for this indication to then support a decision to re-manufacture the drug and use it in a COVID clinical trial.